- Home
- UTG vs PCVX Comparison
UTG vs PCVX Comparison
Compare UTG & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTG
- PCVX
- Stock Information
- Founded
- UTG 2003
- PCVX 2013
- Country
- UTG United States
- PCVX United States
- Employees
- UTG N/A
- PCVX N/A
- Industry
- UTG Investment Managers
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- UTG Finance
- PCVX Health Care
- Exchange
- UTG Nasdaq
- PCVX Nasdaq
- Market Cap
- UTG 3.4B
- PCVX 4.0B
- IPO Year
- UTG N/A
- PCVX 2020
- Fundamental
- Price
- UTG $37.29
- PCVX $33.02
- Analyst Decision
- UTG
- PCVX Strong Buy
- Analyst Count
- UTG 0
- PCVX 8
- Target Price
- UTG N/A
- PCVX $135.00
- AVG Volume (30 Days)
- UTG 317.8K
- PCVX 1.5M
- Earning Date
- UTG 01-01-0001
- PCVX 11-04-2025
- Dividend Yield
- UTG 7.28%
- PCVX N/A
- EPS Growth
- UTG N/A
- PCVX N/A
- EPS
- UTG 9.86
- PCVX N/A
- Revenue
- UTG $96,107,593.00
- PCVX N/A
- Revenue This Year
- UTG N/A
- PCVX N/A
- Revenue Next Year
- UTG N/A
- PCVX N/A
- P/E Ratio
- UTG $3.20
- PCVX N/A
- Revenue Growth
- UTG 8.35
- PCVX N/A
- 52 Week Low
- UTG $25.26
- PCVX $27.66
- 52 Week High
- UTG $35.29
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- UTG 40.83
- PCVX 55.75
- Support Level
- UTG $37.05
- PCVX $30.89
- Resistance Level
- UTG $38.49
- PCVX $32.32
- Average True Range (ATR)
- UTG 0.48
- PCVX 1.19
- MACD
- UTG -0.17
- PCVX 0.30
- Stochastic Oscillator
- UTG 25.14
- PCVX 84.68
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.